Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04279535 · ClinicalTrials.gov registry record · Early Phase 1
Topical Vitamin C for Treatment of Basal Cell Cancer
A Early Phase 1 study, sponsored by Center for Biomedical Research.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT04279535: Completed Early Phase 1 study, sponsored by Center for Biomedical Research.
NCT04279535 is a Early Phase 1 study that has completed, run by Center for Biomedical Research. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04279535, a Early Phase 1 study, has completed, sponsored by Center for Biomedical Research.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.
Interventions
- DRUG Topical Ascorbic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2019-06-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04279535
The ClinicalTrials.gov registry entry for NCT04279535 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Biomedical Research, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topical Ascorbic Acid is the first listed.
NCT04279535 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04279535 about?
NCT04279535 is a clinical study titled "Topical Vitamin C for Treatment of Basal Cell Cancer". Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carci...
What is the current status of trial NCT04279535?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2018-03-01. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT04279535?
The interventions under investigation include: Topical Ascorbic Acid (DRUG).
Who is sponsoring clinical trial NCT04279535?
This trial is sponsored by Center for Biomedical Research, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.